5/3/2013

Atossa Genetics has agreed to allow Millennium Healthcare to offer its ForeCYTE Breast Health system in northern New Jersey and metropolitan New York. Millennium Healthcare's initial order was for 10,000 units of the test kit, which is used for the noninvasive and early detection of breast cancer or precancerous conditions.

Related Summaries